L Sekar

516 total citations
12 papers, 377 citations indexed

About

L Sekar is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, L Sekar has authored 12 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 9 papers in Epidemiology and 2 papers in Pharmacology. Recurrent topics in L Sekar's work include Tuberculosis Research and Epidemiology (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers) and HIV/AIDS drug development and treatment (4 papers). L Sekar is often cited by papers focused on Tuberculosis Research and Epidemiology (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers) and HIV/AIDS drug development and treatment (4 papers). L Sekar collaborates with scholars based in India and United States. L Sekar's co-authors include Soumya Swaminathan, Geetha Ramachandran, Chandrasekaran Padmapriyadarsini, A. K. Hemanth Kumar, N. Ravichandran, Prema Gurumurthy, Prem Venkatesan, S. Rajasekaran, S Bhagavathy and R. Rajeswari and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and The International Journal of Tuberculosis and Lung Disease.

In The Last Decade

L Sekar

12 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L Sekar India	7	318	203	76	74	54	12	377
Hadija Semvua Tanzania	12	267 0.8×	172 0.8×	54 0.7×	51 0.7×	36 0.7×	26	376
Sandra Castel South Africa	11	343 1.1×	183 0.9×	113 1.5×	66 0.9×	80 1.5×	34	498
Linda M. Spooner United States	14	192 0.6×	170 0.8×	34 0.4×	32 0.4×	38 0.7×	27	418
Lina Davies Forsman Sweden	12	381 1.2×	267 1.3×	100 1.3×	108 1.5×	16 0.3×	38	468
Lucilia Pereira Molino Brazil	6	337 1.1×	231 1.1×	128 1.7×	78 1.1×	24 0.4×	8	406
Katharine E. Stott United Kingdom	11	294 0.9×	219 1.1×	47 0.6×	31 0.4×	18 0.3×	23	401
Vincent J. Lempers Netherlands	9	237 0.7×	152 0.7×	89 1.2×	12 0.2×	27 0.5×	9	332
Lavanya Jayabal India	14	366 1.2×	243 1.2×	24 0.3×	86 1.2×	44 0.8×	37	451
N. Ravichandran India	10	270 0.8×	167 0.8×	67 0.9×	72 1.0×	55 1.0×	15	353
Matthew M. Medlock United States	6	268 0.8×	204 1.0×	61 0.8×	28 0.4×	46 0.9×	7	357

Countries citing papers authored by L Sekar

Since Specialization

Citations

This map shows the geographic impact of L Sekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Sekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Sekar more than expected).

Fields of papers citing papers by L Sekar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Sekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Sekar. The network helps show where L Sekar may publish in the future.

Co-authorship network of co-authors of L Sekar

This figure shows the co-authorship network connecting the top 25 collaborators of L Sekar. A scholar is included among the top collaborators of L Sekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Sekar. L Sekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Sekar, L, et al.. (2024). ADVANCEMENTS IN MICRONEEDLE TECHNOLOGY: COMPREHENSIVE INSIGHTS INTO VERSATILE DRUG DELIVERY MECHANISMS. International Journal of Applied Pharmaceutics. 1–11. 4 indexed citations

Ponnuraja, C, et al.. (2021). Prospective study of different postures during the second stage of labour and their outcome. International Journal of Clinical Obstetrics and Gynaecology. 5(1). 234–239. 1 indexed citations

Padmapriyadarsini, Chandrasekaran, et al.. (2020). Effectiveness of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected adults in programme setting. The Indian Journal of Medical Research. 152(6). 648–655. 6 indexed citations

Padmapriyadarsini, Chandrasekaran, et al.. (2018). Effectiveness of symptom screening and incidence of tuberculosis among adults and children living with HIV infection in India.. PubMed. 29(6). 321–325. 9 indexed citations

Padmapriyadarsini, Chandrasekaran, L Sekar, Geetha Ramachandran, et al.. (2017). Factors affecting high-density lipoprotein cholesterol in HIV-infected patients on nevirapine-based antiretroviral therapy. The Indian Journal of Medical Research. 145(5). 641–650. 5 indexed citations

Kumar, A. K. Hemanth, Gopalan Narendran, Rakesh Kumar, et al.. (2015). RMP exposure is lower in HIV-infected TB patients receiving intermittent than daily anti-tuberculosis treatment. The International Journal of Tuberculosis and Lung Disease. 19(7). 805–807. 4 indexed citations

Narendran, Gopalan, Pradeep A. Menon, P. Venkatesan, et al.. (2014). Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretroviral Therapy. Clinical Infectious Diseases. 59(12). 1798–1804. 18 indexed citations

Ramachandran, Geetha, A. K. Hemanth Kumar, Perumal Kannabiran Bhavani, et al.. (2014). Pharmacokinetics of First-Line Antituberculosis Drugs in HIV-Infected Children with Tuberculosis Treated with Intermittent Regimens in India. Antimicrobial Agents and Chemotherapy. 59(2). 1162–1167. 23 indexed citations

Ramachandran, Geetha, Perumal Kannabiran Bhavani, L Sekar, et al.. (2013). Age, nutritional status and INH acetylator status affect pharmacokinetics of anti-tuberculosis drugs in children. The International Journal of Tuberculosis and Lung Disease. 17(6). 800–806. 68 indexed citations

10.

Gurumurthy, Prema, Geetha Ramachandran, A. K. Hemanth Kumar, et al.. (2004). Malabsorption of Rifampin and Isoniazid in HIV‐Infected Patients With and Without Tuberculosis. Clinical Infectious Diseases. 38(2). 280–283. 82 indexed citations

11.

Gurumurthy, Prema, Geetha Ramachandran, A. K. Hemanth Kumar, et al.. (2004). Decreased Bioavailability of Rifampin and Other Antituberculosis Drugs in Patients with Advanced Human Immunodeficiency Virus Disease. Antimicrobial Agents and Chemotherapy. 48(11). 4473–4475. 118 indexed citations

12.

Rajeswari, R., et al.. (2002). Private pharmacies in tuberculosis control--a neglected link.. PubMed. 6(2). 171–3. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact